SCHEMBL29632580

SCHEMBL29632580

C[C@@H]1CN(Cc2cc(N)nc(NC3CCCCC3)c2)C[C@H](C)O1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 8/20 0.46
NUDT1 P36639 2/20 0.43
ABL1 P00519 1/20 0.40
RIN1 Q13671 1/20 0.40
LMNA P02545 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
HTT P42858 1/20 0.37
HDAC6 Q9UBN7 1/20 0.36
KCNN2 Q9H2S1 1/20 0.36
KCNN3 Q9UGI6 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 1/20 0.34
ATM Q13315 1/20 0.34
MAPKAPK2 P49137 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29632634 0.99 HRH4 (0.47) HRH4NUDT1ABL1RIN1LMNA
SCHEMBL29632653 0.93 HRH4 (0.42) HRH4NUDT1ABL1RIN1LMNA
SCHEMBL29632672 0.91 HRH4 (0.41) HRH4NUDT1ABL1RIN1LMNA
SCHEMBL29632671 0.90 HRH4 (0.38) HRH4LMNAHDAC6KDM4ETDP1
SCHEMBL12291021 0.89 HRH4 (0.38) HRH4LMNAHDAC6GAAATM
SCHEMBL12291464 0.89 HRH4 (0.38) HRH4LMNAHDAC6GAAATM
SCHEMBL29632639 0.87 HRH4 (0.36) HRH4ABL1RIN1LMNAHDAC6
SCHEMBL29632613 0.86 HDAC6 (0.38) HRH4NUDT1ABL1RIN1LMNA
SCHEMBL29632690 0.83 HRH4 (0.50) HRH4NUDT1ABL1RIN1LMNA
SCHEMBL807815 0.81 JAK3 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022086284-A1 PROTEIN KINASE INHIBITOR AND USE THEREOF (주)메디톡스 2022-04-28 WO disclosed
WO-2022071772-A1 PROTEIN KINASE INHIBITOR AND USE THEREOF (주)메디톡스 2022-04-07 WO disclosed